Cargando…
Monocarboxylate transporter 1 contributes to growth factor-induced tumor cell migration independent of transporter activity
Tumor progression to metastatic disease contributes to the vast majority of incurable cancer. Understanding the processes leading to advanced stage cancer is important for the development of future therapeutic strategies. Here, we establish a connection between tumor cell migration, a prerequisite t...
Autores principales: | Gray, Alana L., Coleman, David T., Shi, Runhua, Cardelli, James A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078044/ https://www.ncbi.nlm.nih.gov/pubmed/27127175 http://dx.doi.org/10.18632/oncotarget.9016 |
Ejemplares similares
-
Monocarboxylate transporters in cancer
por: Payen, Valéry L., et al.
Publicado: (2019) -
Monocarboxylate transporters in the brain and in cancer()
por: Pérez-Escuredo, Jhudit, et al.
Publicado: (2016) -
Monocarboxylate transporter 1 and monocarboxylate transporter 4 in cancer-endothelial co-culturing microenvironments promote proliferation, migration, and invasion of renal cancer cells
por: Guo, Chen, et al.
Publicado: (2019) -
Cooperative transport mechanism of human monocarboxylate transporter 2
por: Zhang, Bo, et al.
Publicado: (2020) -
Monocarboxylate Transporter 1 (MCT1) is an independent prognostic biomarker in endometrial cancer
por: Latif, Ayşe, et al.
Publicado: (2017)